XTX Topco’s Decoy Therapeutics DCOY Stock Holding History

XTX Topco’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-912	Closed	-$7.1K	–	4333
2025 Q4	$7.1K	Buy	+912	New	+$23.6K	﹤0.01%	3220

Other funds holding DCOY

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's DCOY Position: Q1 2026 in Review

XTX Topco sold out of Decoy Therapeutics (DCOY) in Q1 2026, closing a stake of 912 shares — an estimated $7.1K sold.

XTX Topco first reported a position in DCOY in Q4 2025 and held it in 1 quarter. The position peaked at $7.1K in Q4 2025. 4 funds tracked by Wall St. Rank hold DCOY as of Q1 2026.

XTX Topco reported no remaining Decoy Therapeutics position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 912 Decoy Therapeutics shares in Q1 2026, an estimated $7.1K.
XTX Topco first reported a position in Decoy Therapeutics in Q4 2025 and held it in 1 quarter.
XTX Topco's Decoy Therapeutics position peaked at $7.1K in Q4 2025.
4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.